SCHEMBL9905207

SCHEMBL9905207

CC(C)CN/C(=N\C(=O)c1ccc(F)c(F)c1)Nc1cc(-c2ccc(CO)cc2)n[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
NCOR2 Q9Y618 1/20 0.38
ALPL P05186 3/20 0.36
MAPT P10636 3/20 0.34
TP53 P04637 2/20 0.34
LMNA P02545 1/20 0.34
ABL1 P00519 1/20 0.33
BCR P11274 1/20 0.33
GSK3B P49841 1/20 0.33
ACR P10323 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9905203 1.00 HDAC3 (0.38) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL9905210 1.00 HDAC3 (0.38) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18557797 0.92 HDAC3 (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL19362713 0.92 ALPL (0.40) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18558468 0.88 ALPL (0.38) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18558085 0.88 ALPL (0.36) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18558362 0.86 ALPL (0.43) HDAC6ALPLMAPTTP53LMNA
SCHEMBL17088962 0.86 HDAC3 (0.33) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18558507 0.86 ALPL (0.38) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18558599 0.85 HDAC3 (0.37) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2648511-A1 PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF Lycera Corporation (US) 2013-10-16 EP disclosed
WO-2012078874-A1 PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed